While Artificial Intelligence (AI) has emerged as groundbreaking and significantly impacting various sectors and enhancing quality of life, the chasm between technological advancements and the law is ...

Phase II trial of the EGFR tyrosine kinase inhibitor erlotinib for single agent therapy of recurrent Glioblastoma Multiforme: Interim results No significant financial relationships to disclose. This ...

Please provide your email address to receive an email when new articles are posted on . Recursive partitioning analysis-based TNM stage groupings were associated with significantly improved survival ...